CorMedix (CRMD) Cash from Operations Growth (3y) (2015 - 2025)
CorMedix (CRMD) Cash from Operations Growth (3y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
37.40% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
20.11% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
16.64% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
CorMedix |
631,378.03 |
-154.57 Mn |
107.31 Mn |
158.87% |
| Date | Value |
|---|
| Dec 31, 2025 |
158.87% |
| Sep 30, 2025 |
92.62% |
| Jun 30, 2025 |
95.66% |
| Mar 31, 2025 |
70.15% |
| Dec 31, 2024 |
1.47% |
| Sep 30, 2024 |
-35.36% |
| Jun 30, 2024 |
-65.60% |
| Mar 31, 2024 |
-37.28% |
| Dec 31, 2023 |
-21.89% |
| Sep 30, 2023 |
-5.95% |
| Jun 30, 2023 |
-124.82% |
| Mar 31, 2023 |
-9.27% |
| Dec 31, 2022 |
-16.58% |
| Sep 30, 2022 |
-14.78% |
| Jun 30, 2022 |
-227.77% |
| Mar 31, 2022 |
2.90% |
| Dec 31, 2021 |
6.59% |
| Sep 30, 2021 |
-2.50% |
| Jun 30, 2021 |
10.66% |
| Mar 31, 2021 |
1.75% |
